vimarsana.com

Page 7 - ப்ரோக்ர்யாம் அதிகாரிகள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Program Associate, Sexual Health and Rights

AJWS is an equal opportunity employer and provides competitive salaries and benefits. Overview of AJWS American Jewish World Service (AJWS) is the leading Jewish organization working to promote human rights and end poverty in the developing world. AJWS advances the health and rights of women, girls and LGBTQI+ people; promotes civil and political rights; defends access to food, land and water; and aids communities in the aftermath of disasters. We pursue lasting change by granting approximately $40 million annually to more than 500 grassroots and global human rights organizations in Africa, Asia, Latin America and the Caribbean and by mobilizing our community in the U.S. to advocate for global justice. Working together, we strive to build a more just and equitable world.

Worldwide Antisense Oligonucleotide Therapeutics Industry to 2030 - Market Trends and Global Forecasts

Share this article Share this article ResearchAndMarkets.com s offering. Since the approval of Vitravene (for the treatment of cytomegalovirus retinitis) in 1998, antisense oligonucleotide (ASO) therapies have evolved into a prominent class of therapeutics. In addition to the seven drugs, based on such molecules, that are commercially available, around 160 candidates are under development. Examples of recently approved antisense therapeutics include (in reverse chronological order) Viltepso (duchenne muscular dystrophy, March 2020), Vyondys 53 (duchenne muscular dystrophy, December 2019) and Waylivra (hereditary transthyretin-mediated (hATTR) amyloidosis, May 2019). Given their ability to target the root cause of diseases, at the protein expression level, these disease-modifying interventions have potential applications across a wide range of therapeutic areas (including but not limited to oncological disorders, neurodegenerative disorders, respiratory disorders, and even certain

Dear Colleague Letter: Supplemental Funding for Postdoctoral Researchers to Mitigate COVID-19 Impacts on Research Career Progression (nsf21066) | NSF

NSF 21-066 April 6, 2021 BACKGROUND NSF seeks to lessen the impacts of the COVID-19 pandemic on science, technology, engineering, and mathematics (STEM) research and STEM education research and development. Known impacts include decreased faculty research productivity and difficulty in initiating and/or maintaining a career trajectory in either STEM or STEM education research and development. The goal of this funding opportunity is to support sustained research productivity and career progression of early career researchers who have been disproportionately impacted by the pandemic. Such support could sustain the research careers of new or current postdoctoral researchers, as well as help mitigate pandemic-related reductions in research productivity of early career faculty.

NSS Units of Government Degree College Baramulla facilitates Covid-19 vaccination drive in the campus

Apr 15, 2021 He also impressed upon the college officials, falling in the aforesaid age bracket, to come forward and get vaccinated in order to boost their immunity against the deadly virus. Prof. Lone also stressed that other age groups, including college officials and students be also vaccinated at the earliest. Others who were present on the occasion and facilitated the daylong drive included NSS Program Officers, Prof. Arshad Ahmad Yatoo, Dr. Kaiser Ahmad Dar, and Dr. Syed Masarat Geelani besides NSS volunteers of the college. The drive culminated with a vote of thanks proposed by Dr. A. R. Malik, Secretary, Staff Council of the college.

Senior Program Officer - Middle East

Senior Program Officer - Middle East
reliefweb.int - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from reliefweb.int Daily Mail and Mail on Sunday newspapers.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.